A carregar...
Virtual screening of novel compounds as potential ER-alpha inhibitors
Majority of breast cancers diagnosed today are estrogen receptor (ER)-positive, however, progesterone receptor-positive (PR-positive) is also responsible for breast cancer. Tumors that are ER/PR-positive are much more likely to respond to hormone therapy than tumors that are ER/PR-negative. Nearly 1...
Na minha lista:
| Publicado no: | Bioinformation |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Biomedical Informatics
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6589477/ https://ncbi.nlm.nih.gov/pubmed/31249434 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6026/97320630015321 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|